Edgar Filing: QUINN MICHAEL A

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

QUINN MICHAEL A

2. Issuer Name and Ticker or Trading Symbol
RESMED INC [RMD]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

__X__ Director	_____ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

RESMED INC., 97 WATERLOO ROAD

3. Date of Earliest Transaction (Month/Day/Year)
05/20/2002

(Street)

NORTH RYDE, C3 2113

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
ResMed Common Stock	02/28/2006		C		1,650	A	$ 30.3	1,650	I	Kaylara ATF Kaylara Family Trust ⁽²⁾
ResMed Common Stock	02/28/2006		C		1,650	A	$ 30.3	1,650	I	Kaylara ATF Straflo ⁽²⁾
ResMed Common Stock								74,800	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

ResMed - 4% Convertible Subordinated Notes

$ 30.3

05/20/2002

50,000

⁽¹⁾

06/20/2006

ResMed Common Stock

1,650

$ 91.9236

50,000

Kaylara ATF Kaylara Family Trust ⁽²⁾

ReMed - 4% Convertible Subordinated Notes

$ 30.3

05/20/2002

50,000

⁽¹⁾

06/20/2006

ResMed Common Stock

1,650

$ 91.9236

50,000

Kaylara ATF Straflo ⁽²⁾

ResMed - 4% Convertible Suborddinated Notes

$ 30.3

02/28/2006

50,000

⁽¹⁾

06/20/2006

ResMed Common Stock

1,650

$ 91.9236

Kaylara ATF Kaylara Family Trust ⁽²⁾

ResMed - 4% Convertible Subordinated Notes

$ 30.3

02/28/2006

50,000

⁽²⁾

06/20/2006

ResMed Common Stock

1,650

$ 91.91

Kaylara ATF Straflo ⁽²⁾

ResMed Stock Options

⁽³⁾

ResMed Common Stock ⁽³⁾

⁽³⁾

195,400 ⁽³⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
QUINN MICHAEL A RESMED INC. 97 WATERLOO ROAD NORTH RYDE, C3 2113	X

Signatures

Michael A. Quinn		06/12/2006
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Transaction represents the purchase of ResMed's 4% Convertible Subordinated Notes due 6/20/2006. The Notes can be converted into 33 shares of ResMed Common Stock per $1,000 principal amount of Notes at a conversion price of $30.30 per share.
(2)	The Note holders are Kaylara ATF Kaylara Family Trust and Kaylara ATF Straflo which are entities controlled by Michael Quinn.
(3)	Mr. Quinn also has stock options granted between between 1998 and 2005. Options are exercisable 1/3 each year beginning 1 year after date of grant and expire 10 years after the grant date. Number of options beneficially owned reflects ResMed's 2-for-1 stock split.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.